D. Dekker
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
- Microbiology top 10%
- Antimicrobial Peptides and Activities
Papers in
-
- Heme Oxygenase-1 and Carbon Monoxide 6
-
- Analytical Chemistry and Chromatography 8
- Co-authors
- Frank A. D. T. G. Wagener (6 shared papers)Alwin Scharstuhl (2 shared papers)J. H. M. Berden (1 shared paper)Johan van der Vlag (1 shared paper)Paul Smits (4 shared papers)Mirrin J. Dorresteijn (5 shared papers)Mohamed Amiche (1 shared paper)David M. Burger (2 shared papers)
- Journals
- Journal of Chromatography A (3 papers)Arteriosclerosis Thrombosis and Vascular Biology (2 papers)British Journal of Clinical Pharmacology (1 paper)International Journal of Pharmaceutics (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- NetherlandsGermanyFrance
In The Last Decade
D. Dekker
26 papers receiving 445 citations
Peers
Comparison fields: 5 of 96
- Clinical Biochemistry 43
- Microbiology 39
- Toxicology 16
- Nephrology 33
- Emergency Medicine 44
Countries citing papers authored by D. Dekker
This map shows the geographic impact of D. Dekker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Dekker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Dekker more than expected).
Fields of papers citing papers by D. Dekker
This network shows the impact of papers produced by D. Dekker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Dekker. The network helps show where D. Dekker may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Dekker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 119 | |
| 2 | 2010 | 95 | |
| 3 | 2019 | 46 | |
| 4 | 2009 | 33 | |
| 5 | 1984 | 31 | |
| 6 | 2014 | 20 | |
| 7 | 2017 | 16 | |
| 8 | 2021 | 13 | |
| 9 | 1979 | 11 | |
| 10 | 2022 | 9 | |
| 11 | 1979 | 9 | |
| 12 | 2019 | 8 | |
| 13 | 2020 | 8 | |
| 14 | 1980 | 7 | |
| 15 | 2015 | 6 | |
| 16 | 1980 | 6 | |
| 17 | 1984 | 3 | |
| 18 | 2023 | 3 | |
| 19 | 1980 | 3 | |
| 20 | 1980 | 3 |
About D. Dekker
D. Dekker is a scholar working on Molecular Biology, Spectroscopy, Endocrinology, Diabetes and Metabolism, Pharmacology and Emergency Medicine, having authored 27 papers that have together received 457 indexed citations. Recurring topics across this work include Analytical Chemistry and Chromatography (8 papers), Heme Oxygenase-1 and Carbon Monoxide (6 papers), Analytical Methods in Pharmaceuticals (4 papers), Cannabis and Cannabinoid Research (3 papers), Neonatal Health and Biochemistry (3 papers), Methemoglobinemia and Tumor Lysis Syndrome (2 papers), Poisoning and overdose treatments (2 papers) and Cardiac Arrest and Resuscitation (2 papers). The work is most often cited by research in Clinical Biochemistry (43 citations), Microbiology (39 citations), Toxicology (16 citations), Nephrology (33 citations) and Emergency Medicine (44 citations). D. Dekker has collaborated with scholars based in Netherlands, Germany and France. Frequent co-authors include Frank A. D. T. G. Wagener, Alwin Scharstuhl, J. H. M. Berden, Johan van der Vlag, Paul Smits, Mirrin J. Dorresteijn, Mohamed Amiche, David M. Burger, Suzanne Heemskerk and A. Bult. Their work appears in journals such as Journal of Chromatography A, Arteriosclerosis Thrombosis and Vascular Biology, British Journal of Clinical Pharmacology, International Journal of Pharmaceutics and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.